Pfizer will invest $750 million in its southwest Michigan facility to increase capacity for manufacturing sterile injectable medications — creating 300 new jobs.
The new investment, revealed at a news conference with Gov. Gretchen Whitmer, is focused on Pfizer's modular aseptic processing (MAP). The MAP effort makes it possible for the drugmaker to distribute pre-filled syringes of medication. That effort includes state of the art self-contained, aseptic modular systems and design, according to David Breen, vice president and site leader for Pfizer's Portage manufacturing facility near Kalamazoo, as reported by The Detroit News.
The facility currently employs around 3,000 workers and Pfizer is now looking to fill about another 300 roles. The additional expansion will require hires such as scientists, process engineers, operators, technicians and construction workers
First announced in 2018, Pfizer broke ground on the $465 million MAP project in April 2021. It is located on Pfizer's 1,300-acre global manufacturing campus and part of the drugmaker's promised $1.1 billion investment in Kalamazoo County. The recently announced expansion at the same site is yet another portion of the company's "blueprint to grow" its U.S. manufacturing base, according to Breen.
